NCEZID - National Center for Emerging and Zoonotic Infectious Diseases
Summary Abstract Nanohmics proposes to continue its successful Phase I protect ins which electrochemiluminescence (ECL) from traditional ruthenium trisbipyridine (Ru(bpy)3) in lateral flow (LF) test strips was used to detect as few as 18 Listeria monocytogenes bacteria (25 cfu average). This LOD could improve to 1-2 cfu with the addition of a photomultiplier tube (PMT). LF strip assays are known for being rapid, highly affordable, and facile onsite diagnostics, but generally lack sensitivity and may miss detection of foodborne pathogens (false negative results) at low levels even in time-consuming enrichment cultures. In some cases, LF strip developers have turned to fluorescence for added sensitivity. But, fluorescence has innate autofluorescent background from the excitation of other biological materials in samples, thus limiting its sensitivity. Although traditional chemiluminescence (CL) can be ultrasensitive due to its initial black background and high signal to noise ratios (SNRs), CL is difficult to control spatially on a test strip and requires temporal delays to allow it to reach stable equilibrium prior to measurement which limits reproducibility. However, ECL is simple to control by controlling the working electrode voltage (only about 1.25V), thus enabling battery-operated handheld readers. ECL can also amplify or accrue the signal over time each time the Ru(bpy)3 or quantum dot (Qdot) redox “wheel” is turned electrically to release another red photon, thus giving sensitivity comparable to radioisotopic methods when the ECL signal is integrated over time. Newer Qdot-based ECL techniques promise as much as a million-fold increase in ECL over Ru(bpy)3-antibody or aptamer tags as well. Thus, Nanohmics proposes to build on its successful Phase I effort with Listeria and Ru(bpy)3, by expanding to the other three major foodborne bacterial species (C. jejuni, Shiga toxin producing E. coli O157:H7 and S. enterica serovar Typhimurium) and inactivated enteroviruses in Phase II and using Ru(bpy)3 and/or Qdots for ECL. Titration, LOD and cross-reactivity results from the four major foodborne bacterial diseases will be validated by a third party laboratory (Food Safety Net Services) in Phase II and licensing can be initialized via Nanohmics food safety consultant.
Up to $1.0M
2027-09-29
We'll draft the complete application against NCEZID - National Center for Emerging and Zoonotic Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Subscribe for Pro access · Includes AI drafting + templates + PDF export
Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness
NIMH - National Institute of Mental Health — up to $18.3M
COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I
NCI - National Cancer Institute — up to $15.1M
Leveraging Artificial Intelligence to Predict Mental Health Risk among Youth Presenting to Rural Primary Care Clinics
NIMH - National Institute of Mental Health — up to $15.0M
Feasibility of Genomic Newborn Screening Through Public Health Laboratories
OD - NIH Office of the Director — up to $14.4M
WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL COORDINATING CENTER - TASK AREA A AND A2
NHLBI - National Heart Lung and Blood Institute — up to $10.2M
Metal Exposures, Omics, and AD/ADRD risk in Diverse US Adults
NIA - National Institute on Aging — up to $10.2M